Effect of Chronic Restraint Stress on Human Colorectal Carcinoma Growth in Mice

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Lin, Qiang ^a   Wang, Feifei ^a   Yang, Rong ^a   Zheng, Xinmin ^a,b   Gao, Huibao ^a   Zhang, Ping ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Department of Molecular Biology and Genetics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ADRENERGIC RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NORADRENALIN;

ADRENALIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL PROLIFERATION; CELL VIABILITY; COLORECTAL CARCINOMA; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FEMALE; HORMONE ACTION; HUMAN; HUMAN CELL; IMMOBILIZATION STRESS; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NORADRENALIN BLOOD LEVEL; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT; UPREGULATION;

ADRENERGIC ANTAGONISTS; ANIMALS; ATENOLOL; CELL PROLIFERATION; COLORECTAL NEOPLASMS; EPINEPHRINE; GENE EXPRESSION; HUMANS; MICE; MICE, NUDE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOPLASM TRANSPLANTATION; NOREPINEPHRINE; PHENTOLAMINE; PROPANOLAMINES; PROPRANOLOL; RECEPTORS, ADRENERGIC, BETA; RESTRAINT, PHYSICAL; STRESS, PHYSIOLOGICAL; TUMOR BURDEN; TUMOR CELLS, CULTURED;

MUS; MUS MUSCULUS;

EID: 84876025483     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061435     Document Type: Article

References (75)

1. Tanaka T, (2009) Colorectal carcinogenesis: Review of human and experimental animal studies. J Carcinog 8: 5.
2. Courtney JG, Longnecker MP, Peters RK, (1996) Psychosocial aspects of work and the risk of colon cancer. Epidemiology 7: 175-181.
3. Glaser R, Kiecolt-Glaser JK, (2005) Stress-induced immune dysfunction: implications for health. Nat Rev Immunol 5: 243-251.
4. Antoni MH, Lutgendorf SK, Cole SW, Dhabhar FS, Sephton SE, et al. (2006) The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nat Rev Cancer 6: 240-248.
5. Thaker PH, Lutgendorf SK, Sood AK, (2007) The neuroendocrine impact of chronic stress on cancer. Cell Cycle 6: 430-433.
6. Schmidt C, Kraft K, (1996) Beta-endorphin and catecholamine concentrations during chronic and acute stress in intensive care patients. Eur J Med Res 1: 528-532.
7. Rupp H, Dhalla KS, Dhalla NS, (1994) Mechanisms of cardiac cell damage due to catecholamines: significance of drugs regulating central sympathetic outflow. J Cardiovasc Pharmacol 24Suppl 1: S16-24.
8. Vandewalle B, Revillion F, Lefebvre J, (1990) Functional beta-adrenergic receptors in breast cancer cells. J Cancer Res Clin Oncol 116: 303-306.
9. Marchetti B, Spinola PG, Pelletier G, Labrie F, (1991) A potential role for catecholamines in the development and progression of carcinogen-induced mammary tumors: hormonal control of beta-adrenergic receptors and correlation with tumor growth. J Steroid Biochem Mol Biol 38: 307-320.
10. Badino GR, Novelli A, Girardi C, Di Carlo F, (1996) Evidence for functional beta-adrenoceptor subtypes in CG-5 breast cancer cell. Pharmacol Res 33: 255-260.
11. Enserink JM, Price LS, Methi T, Mahic M, Sonnenberg A, et al. (2004) The cAMP-Epac-Rap1 pathway regulates cell spreading and cell adhesion to laminin-5 through the alpha3beta1 integrin but not the alpha6beta4 integrin. J Biol Chem 279: 44889-44896.
12. Masur K, Niggemann B, Zanker KS, Entschladen F, (2001) Norepinephrine-induced migration of SW 480 colon carcinoma cells is inhibited by beta-blockers. Cancer Res 61: 2866-2869.
13. Lang K, Drell TLt, Lindecke A, Niggemann B, Kaltschmidt C, et al. (2004) Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs. Int J Cancer 112: 231-238.
14. Sood AK, Bhatty R, Kamat AA, Landen CN, Han L, et al. (2006) Stress hormone-mediated invasion of ovarian cancer cells. Clin Cancer Res 12: 369-375.
15. Reiche EM, Nunes SO, Morimoto HK, (2004) Stress, depression, the immune system, and cancer. Lancet Oncol 5: 617-625.
16. Kojima M, Wakai K, Tokudome S, Tamakoshi K, Toyoshima H, et al. (2005) Perceived psychologic stress and colorectal cancer mortality: findings from the Japan Collaborative Cohort Study. Psychosom Med 67: 72-77.
17. Allison PJ, Guichard C, Fung K, Gilain L, (2003) Dispositional optimism predicts survival status 1 year after diagnosis in head and neck cancer patients. J Clin Oncol 21: 543-548.
18. Reynolds P, Kaplan GA, (1990) Social connections and risk for cancer: prospective evidence from the Alameda County Study. Behav Med 16: 101-110.
19. Laconi E, Tomasi C, Curreli F, Diana S, Laconi S, et al. (2000) Early exposure to restraint stress enhances chemical carcinogenesis in rat liver. Cancer Lett 161: 215-220.
20. Steplewski Z, Vogel WH, Ehya H, Poropatich C, Smith JM, (1985) Effects of restraint stress on inoculated tumor growth and immune response in rats. Cancer Res 45: 5128-5133.
21. Ben-Eliyahu S, Page GG, Yirmiya R, Shakhar G, (1999) Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int J Cancer 80: 880-888.
22. Thaker PH, Han LY, Kamat AA, Arevalo JM, Takahashi R, et al. (2006) Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med 12: 939-944.
23. Schuller HM, Tithof PK, Williams M, Plummer H 3rd, (1999) The tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone is a beta-adrenergic agonist and stimulates DNA synthesis in lung adenocarcinoma via beta-adrenergic receptor-mediated release of arachidonic acid. Cancer Res 59: 4510-4515.
24. Weddle DL, Tithoff P, Williams M, Schuller HM, (2001) Beta-adrenergic growth regulation of human cancer cell lines derived from pancreatic ductal carcinomas. Carcinogenesis 22: 473-479.
25. Schuller HM, (2002) Mechanisms of smoking-related lung and pancreatic adenocarcinoma development. Nat Rev Cancer 2: 455-463.
26. Palm D, Lang K, Niggemann B, Drell TLt, Masur K, et al. (2006) The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB/c nude mice is inhibited by beta-blockers. Int J Cancer 118: 2744-2749.
27. Wong HP, Yu L, Lam EK, Tai EK, Wu WK, et al. (2007) Nicotine promotes colon tumor growth and angiogenesis through beta-adrenergic activation. Toxicol Sci 97: 279-287.
28. Zhang D, Ma QY, Hu HT, Zhang M, (2010) beta2-adrenergic antagonists suppress pancreatic cancer cell invasion by inhibiting CREB, NFkappaB and AP-1. Cancer Biol Ther 10: 19-29.
29. Rivera CA, Droguett DA, Kemmerling U, Venegas BA, (2011) Chronic restraint stress in oral squamous cell carcinoma. J Dent Res 90: 799-803.
30. Yin D, Zhang Y, Stuart C, Miao J, Zhang Y, et al. (2006) Chronic restraint stress modulates expression of genes in murine spleen. J Neuroimmunol 177: 11-17.
31. Yin D, Tuthill D, Mufson RA, Shi Y, (2000) Chronic restraint stress promotes lymphocyte apoptosis by modulating CD95 expression. J Exp Med 191: 1423-1428.
32. Sheridan JF, Dobbs C, Jung J, Chu X, Konstantinos A, et al. (1998) Stress-induced neuroendocrine modulation of viral pathogenesis and immunity. Ann N Y Acad Sci 840: 803-808.
33. Guo JS, Chau JF, Cho CH, Koo MW, (2005) Partial sleep deprivation compromises gastric mucosal integrity in rats. Life Sci 77: 220-229.
34. Augsten M, Hagglof C, Olsson E, Stolz C, Tsagozis P, et al. (2009) CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth. Proc Natl Acad Sci U S A 106: 3414-3419.
35. Radojcic T, Baird S, Darko D, Smith D, Bulloch K, (1991) Changes in beta-adrenergic receptor distribution on immunocytes during differentiation: an analysis of T cells and macrophages. J Neurosci Res 30: 328-335.
36. Abrass CK, O'Connor SW, Scarpace PJ, Abrass IB, (1985) Characterization of the beta-adrenergic receptor of the rat peritoneal macrophage. J Immunol 135: 1338-1341.
37. Zschauer AO, Sielczak MW, Smith DA, Wanner A, (1997) Norepinephrine-induced contraction of isolated rabbit bronchial artery: role of alpha 1- and alpha 2-adrenoceptor activation. J Appl Physiol 82: 1918-1925.
38. Souza RF, Shewmake K, Pearson S, Sarosi GA Jr, Feagins LA, et al. (2004) Acid increases proliferation via ERK and p38 MAPK-mediated increases in cyclooxygenase-2 in Barrett's adenocarcinoma cells. Am J Physiol Gastrointest Liver Physiol 287: G743-748.
39. Tominaga K, Higuchi K, Sasaki E, Suto R, Watanabe T, et al. (2004) Correlation of MAP kinases with COX-2 induction differs between MKN45 and HT29 cells. Aliment Pharmacol Ther 20Suppl 1: 143-150.
40. Shin VY, Wu WK, Chu KM, Koo MW, Wong HP, et al. (2007) Functional role of beta-adrenergic receptors in the mitogenic action of nicotine on gastric cancer cells. Toxicol Sci 96: 21-29.
41. Calcagno SR, Li S, Colon M, Kreinest PA, Thompson EA, et al. (2008) Oncogenic K-ras promotes early carcinogenesis in the mouse proximal colon. Int J Cancer 122: 2462-2470.
42. Haigis KM, Kendall KR, Wang Y, Cheung A, Haigis MC, et al. (2008) Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon. Nat Genet 40: 600-608.
43. McEwen BS, (2000) Allostasis and allostatic load: implications for neuropsychopharmacology. Neuropsychopharmacology 22: 108-124.
44. Glaser R, MacCallum RC, Laskowski BF, Malarkey WB, Sheridan JF, et al. (2001) Evidence for a shift in the Th-1 to Th-2 cytokine response associated with chronic stress and aging. J Gerontol A Biol Sci Med Sci 56: M477-482.
45. Page GG, Ben-Eliyahu S, (1999) A role for NK cells in greater susceptibility of young rats to metastatic formation. Dev Comp Immunol 23: 87-96.
46. Lutgendorf SK, Sood AK, Anderson B, McGinn S, Maiseri H, et al. (2005) Social support, psychological distress, and natural killer cell activity in ovarian cancer. J Clin Oncol 23: 7105-7113.
47. Andersen BL, Farrar WB, Golden-Kreutz DM, Glaser R, Emery CF, et al. (2004) Psychological, behavioral, and immune changes after a psychological intervention: a clinical trial. J Clin Oncol 22: 3570-3580.
48. Lee JW, Shahzad MM, Lin YG, Armaiz-Pena G, Mangala LS, et al. (2009) Surgical stress promotes tumor growth in ovarian carcinoma. Clin Cancer Res 15: 2695-2702.
49. Tsuchiya Y, Sawada S, Yoshioka I, Ohashi Y, Matsuo M, et al. (2003) Increased surgical stress promotes tumor metastasis. Surgery 133: 547-555.
50. Liu H, Wang Z, (2005) Effects of social isolation stress on immune response and survival time of mouse with liver cancer. World J Gastroenterol 11: 5902-5904.
51. Armaiz-Pena GN, (2008) ((2008)) Chronic stress promotes tumor growth through a Src-dependent mechanism in a mouse model of ovarian cancer. Brain, Behavior, and Immunity 22: 8-14.
52. Shahzad MM, Arevalo JM, Armaiz-Pena GN, Lu C, Stone RL, et al. (2010) Stress Effects on FosB- and Interleukin-8 (IL8)-driven Ovarian Cancer Growth and Metastasis. J Biol Chem 285: 35462-35470.
53. Basu S, Nagy JA, Pal S, Vasile E, Eckelhoefer IA, et al. (2001) The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor. Nat Med 7: 569-574.
54. Lara HE, Dorfman M, Venegas M, Luza SM, Luna SL, et al. (2002) Changes in sympathetic nerve activity of the mammalian ovary during a normal estrous cycle and in polycystic ovary syndrome: Studies on norepinephrine release. Microsc Res Tech 59: 495-502.
55. Lara HE, Porcile A, Espinoza J, Romero C, Luza SM, et al. (2001) Release of norepinephrine from human ovary: coupling to steroidogenic response. Endocrine 15: 187-192.
56. Mravec B, Tillinger A, Bodnar I, Nagy GM, Palkovits M, et al. (2008) The response of plasma catecholamines in rats simultaneously exposed to immobilization and painful stimuli. Ann N Y Acad Sci 1148: 196-200.
57. Wong HP, Li ZJ, Shin VY, Tai EK, Wu WK, et al. (2009) Effects of Cigarette Smoking and Restraint Stress on Human Colon Tumor Growth in Mice. Digestion 80: 209-214.
58. Leshan L, (1959) Psychological states as factors in the development of malignant disease: a critical review. J Natl Cancer Inst 22: 1-18.
59. Frick LR, Rapanelli M, Bussmann UA, Klecha AJ, Arcos ML, et al. (2009) Involvement of thyroid hormones in the alterations of T-cell immunity and tumor progression induced by chronic stress. Biol Psychiatry 65: 935-942.
60. Moreno-Smith M, Lu C, Shahzad MM, Pena GN, Allen JK, et al. (2011) Dopamine blocks stress-mediated ovarian carcinoma growth. Clin Cancer Res 17: 3649-3659.
61. Teunis MA, Kavelaars A, Voest E, Bakker JM, Ellenbroek BA, et al. (2002) Reduced tumor growth, experimental metastasis formation, and angiogenesis in rats with a hyperreactive dopaminergic system. Faseb J 16: 1465-1467.
62. Askari MD, Tsao MS, Schuller HM, (2005) The tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone stimulates proliferation of immortalized human pancreatic duct epithelia through beta-adrenergic transactivation of EGF receptors. J Cancer Res Clin Oncol 131: 639-648.
63. Hasegawa H, Saiki I, (2002) Psychosocial stress augments tumor development through beta-adrenergic activation in mice. Jpn J Cancer Res 93: 729-735.
64. Al-Wadei HA, Al-Wadei MH, Schuller HM, (2009) Prevention of pancreatic cancer by the beta-blocker propranolol. Anticancer Drugs 20: 477-482.
65. Shin VY, Jin HC, Ng EK, Yu J, Leung WK, et al. (2008) Nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induce cyclooxygenase-2 activity in human gastric cancer cells: Involvement of nicotinic acetylcholine receptor (nAChR) and beta-adrenergic receptor signaling pathways. Toxicol Appl Pharmacol 233: 254-261.
66. Zhang D, Ma Q, Shen S, Hu H, (2009) Inhibition of pancreatic cancer cell proliferation by propranolol occurs through apoptosis induction: the study of beta-adrenoceptor antagonist's anticancer effect in pancreatic cancer cell. Pancreas 38: 94-100.
67. Slotkin TA, Zhang J, Dancel R, Garcia SJ, Willis C, et al. (2000) Beta-adrenoceptor signaling and its control of cell replication in MDA-MB-231 human breast cancer cells. Breast Cancer Res Treat 60: 153-166.
68. Mikami M, Goubaeva F, Song JH, Lee HT, Yang J, (2008) beta-Adrenoceptor blockers protect against staurosporine-induced apoptosis in SH-SY5Y neuroblastoma cells. Eur J Pharmacol 589: 14-21.
69. Schuller HM, Porter B, Riechert A, (2000) Beta-adrenergic modulation of NNK-induced lung carcinogenesis in hamsters. J Cancer Res Clin Oncol 126: 624-630.
70. Wu WK, Wong HP, Luo SW, Chan K, Huang FY, et al. (2005) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone from cigarette smoke stimulates colon cancer growth via beta-adrenoceptors. Cancer Res 65: 5272-5277.
71. Wong HP, Yu L, Lam EK, Tai EK, Wu WK, et al. (2007) Nicotine promotes cell proliferation via alpha7-nicotinic acetylcholine receptor and catecholamine-synthesizing enzymes-mediated pathway in human colon adenocarcinoma HT-29 cells. Toxicol Appl Pharmacol 221: 261-267.
72. Seya Y, Fukuda T, Isobe K, Kawakami Y, Takekoshi K, (2006) Effect of norepinephrine on RhoA, MAP kinase, proliferation and VEGF expression in human umbilical vein endothelial cells. Eur J Pharmacol 553: 54-60.
73. Kim MO, Na SI, Lee MY, Heo JS, Han HJ, (2008) Epinephrine increases DNA synthesis via ERK1/2s through cAMP, Ca(2+)/PKC, and PI3K/Akt signaling pathways in mouse embryonic stem cells. J Cell Biochem 104: 1407-1420.
74. Dhillon AS, Hagan S, Rath O, Kolch W, (2007) MAP kinase signalling pathways in cancer. Oncogene 26: 3279-3290.
75. Ruscica M, Dozio E, Motta M, Magni P, (2007) Modulatory actions of neuropeptide Y on prostate cancer growth: role of MAP kinase/ERK 1/2 activation. Adv Exp Med Biol 604: 96-100.